Bio-Techne Corporation

• Bio-Techne Corporation Estimates – SWB:TE1
  TradingView · 23 Oct 2026
• Ademi LLP investigates Bio-Techne sale to Merck KGaA
  scanx.trade · 14 Oct 2026
• Bio-Techne opens GMP small-molecule manufacturing facility in Bristol
  Pharmafile · 13 Oct 2026
• Bio-Techne opens GMP small molecule facility in Bristol, UK
  Pharmaceutical Technology · 09 Oct 2026
• Bio-Techne expands global GMP manufacturing network with new Bristol facility to advance scalable cell therapy development
  News-Medical · 08 Oct 2026
• Bio-Techne opens GMP manufacturing facility in Bristol to support cell therapy development
  BioProcess International · 08 Oct 2026
• Bio-Techne opens GMP manufacturing facility in Bristol, UK
  Investing.com · 08 Oct 2026
• NASDAQ listed Bio-Techne hails South West’s fast-growing life sciences sector as it opens Bristol cell therapy facility
  TheBusinessDesk.com · 08 Oct 2026
• Bio-Techne Expands Global Gmp Manufacturing Network With New Bristol Facility To Advance Scalable Cell Therapy Development
  TradingView · 08 Oct 2026
• Robert V Baumgartner Exercises Options, Realizes $754K - Bio-Techne (NASDAQ:TECH)
  Benzinga · 25 Sep 2026
• Bio-Techne Shareholders Approve Acquisition by Merck KGaA
  BioPharma APAC · 25 Sep 2026
• Bio-Techne Shareholders Approve Acquisition By Merck As U.S. Antitrust Waiting Period Expires
  Pulse 2.0 · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →